Nanxi Chen
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
-
- Extracellular vesicles in disease 3
- Genomics, phytochemicals, and oxidative stress 1
-
- Advanced Drug Delivery Systems 3
- Advancements in Transdermal Drug Delivery 2
- Co-authors
- Bo Xiao (8 shared papers)Menghang Zu (5 shared papers)Brandon S.B. Canup (3 shared papers)Fangyin Dai (3 shared papers)Yuqi Liang (2 shared papers)Qiubing Chen (1 shared paper)Qian Li (1 shared paper)Liang Zeng (1 shared paper)
- Journals
- Acta Pharmaceutica Sinica B (2 papers)Journal of Nanobiotechnology (1 paper)Expert Opinion on Drug Delivery (1 paper)Journal of Drug Delivery Science and Technology (1 paper)Nanoscale (1 paper)
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Nanxi Chen
10 papers receiving 693 citations
Nanxi Chen's Hit Papers
Peers
Comparison fields: 5 of 73
- Cancer Research 173
- Pharmaceutical Science 60
- Molecular Medicine 36
- Molecular Biology 439
- Biomaterials 55
Countries citing papers authored by Nanxi Chen
This map shows the geographic impact of Nanxi Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanxi Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanxi Chen more than expected).
Fields of papers citing papers by Nanxi Chen
This network shows the impact of papers produced by Nanxi Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanxi Chen. The network helps show where Nanxi Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Nanxi Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Natural exosome-like nanovesicles from edible tea flowers suppress metastatic breast cancer via ROS generation and microbiota modulation Hit paper breakdown → | 2021 | 257 |
| 2 | ‘Green’ nanotherapeutics from tea leaves for orally targeted prevention and alleviation of colon diseases Hit paper breakdown → | 2021 | 242 |
| 3 | 2020 | 49 | |
| 4 | 2024 | 47 | |
| 5 | 2022 | 33 | |
| 6 | 2024 | 26 | |
| 7 | 2021 | 23 | |
| 8 | 2024 | 10 | |
| 9 | 2021 | 9 | |
| 10 | 2025 | 1 |
About Nanxi Chen
Nanxi Chen is a scholar working on Molecular Biology, Pharmaceutical Science, Molecular Medicine, Biomaterials and Biomedical Engineering, having authored 10 papers that have together received 697 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (3 papers), Extracellular vesicles in disease (3 papers), Curcumin's Biomedical Applications (3 papers), Advancements in Transdermal Drug Delivery (2 papers), Nanoplatforms for cancer theranostics (2 papers), Silk-based biomaterials and applications (1 paper), Genomics, phytochemicals, and oxidative stress (1 paper) and Nanoparticle-Based Drug Delivery (1 paper). The work is most often cited by research in Cancer Research (173 citations), Pharmaceutical Science (60 citations), Molecular Medicine (36 citations), Molecular Biology (439 citations) and Biomaterials (55 citations). Nanxi Chen has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Bo Xiao, Menghang Zu, Brandon S.B. Canup, Fangyin Dai, Yuqi Liang, Qiubing Chen, Qian Li, Liang Zeng, Liyong Luo and Chenhui Wang. Their work appears in journals such as Acta Pharmaceutica Sinica B, Journal of Nanobiotechnology, Expert Opinion on Drug Delivery, Journal of Drug Delivery Science and Technology and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.